EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics

Laure Peyro-Saint-Paul iD, Clémence Bechade iD, Alexandre Cesbron, Danièle Debruyne, Marie Brionne, Sylvie Brucato, Mélanie Hanoy, Audrey Dumont, Anais R Briant, Jean-Jacques Parienti, Thierry Lobbedez iD, Maxence Ficheux

Nephrology Dialysis Transplantation · 31.07.2023 · 38 (8) · 1918-1920

DOI: 10.1093/ndt/gfad087 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 11.05.2023. Verfasst von Laure Peyro-Saint-Paul und 11 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Caen Normandie, Department of Clinical Research and Biostatistics, Caen, France. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Peritoneal Dialysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Health Ministry, PHRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Failure, ChronicPeritoneal DialysisHumansPyrazolesPyridonesRenal Dialysis

Substanzen

apixabanPyrazolesPyridones

Autor:innen und Institutionen

  • CHU de Caen Normandie, Department of Clinical Research and Biostatistics, Caen, France.
  • Department of Nephrology, Normandie University, UNICAEN, CHU de Caen Normandie, Caen, France.
  • ANTICIPE, U1086 INSERM-UCN, Centre François Baclesse, Caen, France.
  • CHU de Caen Normandie, Pharmacologie, Caen, France.
  • CHU de Caen Normandie, Hématologie Biologique, Caen, France.
  • CHU de Caen Normandie, Centre de Recherche Clinique, Caen, France.

ORCID-Profile: Laure Peyro-Saint-Paul, Clémence Bechade, Thierry Lobbedez

Förderung

  • French Health Ministry
  • PHRC

Zitieren

APA

Peyro-Saint-Paul, L., Bechade, C., Cesbron, A., Debruyne, D., Brionne, M., Brucato, S., Hanoy, M., Dumont, A., Briant, A. R., Parienti, J. J., Lobbedez, T., & Ficheux, M. (2023). Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics. Nephrology Dialysis Transplantation, 38(8), 1918-1920. https://doi.org/10.1093/ndt/gfad087

Vancouver

Peyro-Saint-Paul L, Bechade C, Cesbron A, Debruyne D, Brionne M, Brucato S, et al. Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics. Nephrology Dialysis Transplantation. 2023;38(8):1918-1920. doi:10.1093/ndt/gfad087

BibTeX
@article{PeyroSaintPaul2023,
  author = {Peyro-Saint-Paul, Laure and Bechade, Clémence and Cesbron, Alexandre and Debruyne, Danièle and Brionne, Marie and Brucato, Sylvie and Hanoy, Mélanie and Dumont, Audrey and Briant, Anais R and Parienti, Jean-Jacques and Lobbedez, Thierry and Ficheux, Maxence},
  title = {Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {8},
  pages = {1918--1920},
  doi = {10.1093/ndt/gfad087}
}
Kostenlos starten →